• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A

ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A

December 10, 2014 By MassDevice Contributors Network

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Zimmer proposes divestitures for EU regulators in Biomet deal

Zimmer said today that it’s proposing to sell of some of its knee and elbow assets in Europe to satisfy anti-trust regulators on the European Commission about its pending, $13.35 billion acquisition of cross-town orthopedics rival Biomet.

“Zimmer has been working closely with the EC to develop a mutually-acceptable solution to address the discrete concerns identified by the EC in its preliminary assessment of the proposed acquisition of Biomet,” the company said. Read more

China, South Korea OK Medtronic's $43B Covidien buy

December 4, 2014 by Mark Hollmer

China, South Korea OK Medtronic's $43B Covidien buy

Chinese regulatory authorities have signed off on the planned $43 billion merger between Medtronic and Covidien, a major milestone as both companies push to conclude the transaction by end of the 2015 1st quarter.

The Chinese Ministry of Commerce’s clearance of the massive deal comes in tandem with the South Korean Fair Trade Commission’s acceptance of the M&A agreement, Medtronic said today. As well, the companies now have all necessary antitrust clearances in hand. Read more

BTG to buy PneumRx for up to $475m

December 4, 2014 by MassDevice

BTG to buy PneumRx for up to $475m

BTG, the healthcare group best known for treating rattlesnake bites and varicose veins, is expanding into lung care by buying a California firm that has developed a device to prop open airways.

The British company said today that it would pay an initial $230 million and up to $245 million in performance-related milestones to acquire privately-owned PneumRx. Read more

BD prices $6.2B bond issue for CareFusion buy

December 5, 2014 by Brad Perriello

BD prices $6.2B bond issue for CareFusion buy

Becton Dickinson priced a debt offering yesterday that it plans to use to consummate its $12.2 billion offer for CareFusion.

The offering entails 5 sets of senior unsecured bonds worth a collective $6.2 billion. Read more

Danaher's Leica division closes Devicor Medical buy

December 4, 2014 by Brad Perriello

Danaher's Leica division closes Devicor Medical buy

Danaher said today that its Leica Biosystems division closed its buyout of Devicor Medical Products, a developer of breast biopsy products.

Leica Biosystems specializes in automated cancer diagnostics. Financial terms were not disclosed. Read more

Filed Under: Mergers & Acquisitions, News Well Tagged With: becton dickinson, Biomet, BTG, CareFusion Corp., Covidien, Danaher Corp., Devicor Medical Products, European Commission, Leica Biosystems, PneumRx Inc., Zimmer Biomet

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy